Home LiteratureArticle Details
PMID: 6807846 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Contribution of toxin A and elastase to virulence of Pseudomonas aeruginosa in chronic lung infections of rats.

Infection and immunity ·Vol. 36 ·No. 3 ·1982-06-00 ·Pages 1223-8

Woods DE, Cryz SJ, Friedman RL, Iglewski BH

Abstract

A chronic pulmonary infection model in rats was employed to assess the role of individual Pseudomonas aeruginosa exoproducts in disease due to this organism. Groups of rats were inoculated transtracheally with agar beads in which were embedded approximately 10(4) colony-forming units of P. aerugijnosa PAO and the PAO derivatives PR1, T1, E64, and a mixture of T1 and E64 in equal numbers (10(4)). Eight animals from each group were sacrificed at 3, 9, and 30 days after challenge, and their lungs were examined for histopathological changes, bacterial numbers, and the presence of P. aeruginosa exoproducts. The Tox- mutant T1 and the PR1 mutant, which produces enzymatically inactive toxin A, were both found to be less virulent in the rat lung model than was the toxigenic parental strain PAO. Pathological changes seen in animals infected with these mutants were restricted to intra- and peribronchial inflammation, whereas the toxigenic parental strain caused parenchymal changes, including a dense mononuclear-cell infiltration in the alveolar spaces in addition to intra- and peribronchial inflammation. Additionally, mutant E64, which produces a temperature-sensitive elastase, was also found to be less virulent in the rat lung model than was the parental strain. These data demonstrate that both active toxin A and elastase are required for maximum virulence of P. aeruginosa in this model.

MeSH Terms
Bacterial Toxins/physiology Lung Diseases/microbiology,pathology Pancreatic Elastase/metabolism Pseudomonas Infections/microbiology,pathology Pseudomonas aeruginosa/pathogenicity
Chemicals
Bacterial Toxins toxin A (Pseudomonas) Pancreatic Elastase
Authors & Affiliations
4 authors, click to expand affiliations / ORCID
Woods D E
Cryz S J
Friedman R L
Iglewski B H
References (23)
23 references, click to expand
  1. Exotoxins of Pseudomonas aeruginosa. 3. Characteristics of antitoxin A.
    J Infect Dis. 1973 Oct;128(4):520-6 PMID: 4200593
  2. Pneumonia in an intensive care unit. A 30-month experience.
    Arch Intern Med. 1974 Jul;134(1):106-11 PMID: 4365670
  3. Extracellular toxins of Pseudomonas aeruginosa.
    J Infect Dis. 1974 Nov;130 Suppl(0):S94-9 PMID: 4370620
  4. Cystic fibrosis: the ciliary inhibitor is a small polypeptide associated with immunoglobulin G.
    Biochem Biophys Res Commun. 1975 Jun 16;64(4):1310-5 PMID: 1137600
  5. Neutralizing antibody to Pseudomonas aeruginosa exotoxin in human sera: evidence for in vivo toxin production during infection.
    Infect Immun. 1976 Oct;14(4):942-7 PMID: 825470
  6. Exotoxin production by clinical isolates of pseudomonas aeruginosa.
    Infect Immun. 1977 Mar;15(3):776-80 PMID: 404244
  7. Pseudomonas: the compromised host.
    Hosp Pract. 1976 Aug;11(8):91-100 PMID: 829230
  8. Incidence of exotoxin production by Pseudomonas species.
    Infect Immun. 1977 Apr;16(1):362-6 PMID: 68931
  9. Passive protection by antitoxin in experimental Pseudomonas aeruginosa burn infections.
    Infect Immun. 1977 Dec;18(3):596-602 PMID: 412786
  10. Purification and properties of a protease with elastase activity from Pseudomonas aeruginosa.
    J Gen Microbiol. 1977 Dec;103(2):319-27 PMID: 413876
  11. Antibodies to proteases and exotoxin A of Pseudomonas aeruginosa in patients with cystic fibrosis: Demonstration by radioimmunoassay.
    J Infect Dis. 1978 Jul;138(1):49-8 PMID: 98596
  12. Comparative toxicities of diphtherial toxin and Pseudomonas aeruginosa exotoxin A: evidence for different cell receptors.
    J Gen Microbiol. 1978 Oct;108(2):333-7 PMID: 102734
  13. A rat model of chronic respiratory infection with Pseudomonas aeruginosa.
    Am Rev Respir Dis. 1979 Mar;119(3):453-9 PMID: 109021
  14. Toxin inhibitors of protein synthesis: production, purification, and assay of Pseudomonas aeruginosa toxin A.
    Methods Enzymol. 1979;60:780-93 PMID: 111001
  15. Chromosomal genetics of Pseudomonas.
    Microbiol Rev. 1979 Mar;43(1):73-102 PMID: 111024
  16. Inhibitory effect of cystic fibrosis serum on pseudomonas phagocytosis by rabbit and human alveolar macrophages.
    Pediatr Res. 1979 Sep;13(9):1085-8 PMID: 116188
  17. Isolation and characterization of Pseudomonas aeruginosa PAO mutant that produces altered elastase.
    J Bacteriol. 1980 Jun;142(3):836-42 PMID: 6769912
  18. Toxin A-deficient mutants of Pseudomonas aeruginosa PA103: isolation and characterization.
    Infect Immun. 1980 Jun;28(3):899-908 PMID: 6772570
  19. Production of alkaline protease by Pseudomonas aeruginosa.
    J Clin Microbiol. 1980 Jul;12(1):131-3 PMID: 6775004
  20. Evidence for the role of toxin A in the pathogenesis of infection with Pseudomonas aeruginosa in humans.
    J Infect Dis. 1980 Oct;142(4):538-46 PMID: 6777437
  21. Corneal infections in mice with toxin A and elastase mutants of Pseudomonas aeruginosa.
    J Infect Dis. 1980 Oct;142(4):547-55 PMID: 6904461
  22. Isolation and characterization of a Pseudomonas aeruginosa mutant producing a nontoxic, immunologically crossreactive toxin A protein.
    Proc Natl Acad Sci U S A. 1980 Dec;77(12):7199-203 PMID: 6261247
  23. PSEUDOMONAS AERUGINOSA ELASTASE. ISOLATION, CRYSTALLIZATION, AND PRELIMINARY CHARACTERIZATION.
    J Biol Chem. 1965 Aug;240:3295-304 PMID: 14321366
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
1982-06-00
Pages
1223-8
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC551460
Subset
IM
Grants
NIAID NIH HHS · AI 14671 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com